Preferences in Communicating Cardiovascular Medication Benefits

Patients’ Preferences for Ways to Communicate Benefits of Cardiovascular Medication

Abstract

Purpose: To determine patients’ willingness to take preventive cardiovascular disease (CVD) medication in relation to their 5-year CVD risk score and modes of communicating benefits of therapy.
Methods:
- 934 patients from family practitioners’ waiting rooms in Auckland, New Zealand were studied.
- Patients knew their 5-year CVD risk (5% to 30%).
- Patients rated how much various modes of communicating the benefits of therapy would encourage them to take medication daily, where the benefits from medication were proportional to their estimated CVD risk score.
Results:
- Patients’ rankings for modes of communicating the benefits of therapy were little influenced by sex, age, ethnicity, numeracy score, 5-year CVD risk, or concern about a heart attack.
- Patients preferred relative risk reduction, with absolute risk reduction rated second overall and numbers needed to treat the least likely to be persuasive.
- Preferences covered the full range and were not predictable from demographic or 5-year CVD risk data.
- 55.1% preferred pictures to numbers, with a people-chart or a bar chart being equally favored.
- 61.8% preferred a doctor’s opinion to any presentation by numbers or pictures.
Conclusions: Patients’ willingness to take preventive cardiovascular medication depends more on mode of communicating treatment benefit than on their short-term CVD risk score or their level of concern about a future cardiovascular event. Because individual preferences were not predictable, more than 1 modality is likely to be clinically useful for each patient.

Introduction

Primary health clinicians use population-based data on the probability of cardiovascular disease (CVD) as a basis for offering interventions to individual patients.
In New Zealand, calculations include adjustments for ethnicity, high-risk diabetes subgroups, and family history.
Decisions can be complex and often accompanied by uncertainty when applying population data to themselves.
There is scarce evidence that the relevant information is effectively communicated to patients.
Patient decision making is not fully rational; patients do not make uniform and predictable decisions based on the same information or on the same information presented in differing ways.
Patients express a strong preference for some modes of communicating treatment benefits over others—preferring pictures to words and relative risk reduction to other numerical presentations.
Physicians and drug companies alike can influence their patients’ decision making, which can potentially have a serious impact on health care outcomes.
Physicians are likely to be highly inaccurate when quantifying their own or their patients’ CVD risk without a calculator or decision aid.
A systematic review of individualized risk communication based on the individual’s own risk factors or risk for a condition has been associated with increased uptake of screening tests.
Previous studies of communicating benefits for CVD prevention have included only high-risk patients or patients who do not know their own short-term CVD risk score.
This study seeks to extend previous work to include a wide range of modes of communicating treatment benefits across patients with a wide range of CVD risk (including primary and secondary prevention), where the scenario is made realistic by adapting the questions and treatment benefits to the CVD risk score of each respondent.
The study aims to determine patients’ willingness to take CVD medication in relation to their 5-year CVD risk score and the modes of communicating benefits of therapy.

Methods

Setting: The study sample was drawn from patients attending 9 Auckland family medicine practices in 2007 to 2009 from low-, middle-, and high-socioeconomic areas, including 2 practices with a high proportion of Māori and Pacific Islanders.
New Zealand guidelines recommend cardiovascular screening for Māori and Pacific Islanders 10 years earlier than recommended for other populations, and for men 10 years earlier than women, because of the higher burden of heart disease at a younger age for Māori, Pacific Islanders, and men.
At the time, all patients would have paid NZ$3 for 3 months of subsidized cardiovascular medications.
Participants: A research assistant invited consecutive patients to participate and obtained written consent. Patients completed a version of the questionnaire most appropriate to their 5-year CVD risk.
Percentage risk was provided from their electronic health records with the patient’s consent, or estimated by the research assistant using a Framingham-based risk calculation color chart using the patients’ age, sex, ethnicity, smoking status, and history of hypertension, diabetes, or a CVD event.
Participants could complete the questionnaire during a face-to-face interview, by telephone with the research assistant, or return it by mail using a prepaid envelope.
Patients younger than 30 years, unable to speak English, with dementia, intoxicated with alcohol, or had taken part in the previous study were excluded.
Questionnaire: The questionnaire used in the previous study was adapted for a new audience and pilot tested by the investigators.
Questionnaires were tailored to a 5-year CVD risk of 5%, 10%, 15%, 20%, 25%, and 30%.
Patients were asked to consider a new medication with few side-effects to be taken daily to reduce their chance of having a heart attack in the next 5 years.
Heart attack was chosen because the estimated risk reduction used in the questionnaire was based on a meta-analysis of lipid-lowering drug use for primary prevention of coronary heart disease.
Questions specified their risk of heart attack, it is strongly correlated with their 5-year CVD risk.
The questionnaire included 5 numerical modes of communicating treatment benefits: relative risk, absolute risk, odds, number needed to treat, and natural frequencies.
The same information was presented in 2 pictorial forms (bar graphs and 10×10 people charts).
Patients ranked the numerical modes of risk communication in order of those that “would encourage you to take this medication every day,” and in order of which “statement helps you make a decision.”
Questions also addressed patients’ preference for the type of pictorial representation, numbers vs pictures, and framing that is positive (99% success) or negative (1% failure).
A causal sequence of perceptions and attitudes was assumed in which real cardiovascular risk leads to perceived likelihood of myocardial infarction, which leads to concern about a myocardial infarction, which leads to keenness to take medication.
Patients rated their perceived likelihood of having a heart attack in the next 5 years on a scale from 1 (not likely) to 10 (very likely), their concern about having a heart attack on a scale from 1 (not concerned at all) to 10 (extremely concerned), and how they felt about taking daily preventative medication on a scale from 1 (not keen at all) to 10 (keen to take medication).
Data was collected on sex, age, ethnicity, and educational level.
Patients were assigned a numeracy score between 0 and 3 based on their understanding of probability, percentages, and proportions using the numeracy test developed by Schwartz et al.
Social deprivation quintile was calculated from the patients’ residential address and NZDep (index of deprivation) scores.
Patients were also asked whether they followed horse racing to test a hypothesis that their interest might correlate with a preference for risk expression using odds.

Analysis

Stata 10.1 (StataCorp LP, College Station, Texas) was used to analyze the data.
$χ^2$ was used to compare simple proportions, linear regressions to examine associations of continuous or ordinal variables (such as CVD risk), logistic regressions to examine associations of binary variables (such as preference for pictures over numbers), and multinomial logistic regression to examine associations with a series of related binary variables (in this case a first-ranked preference for relative risk compared with a first-ranked preference for each of the other numerical modes of expressing risk); statistical significance was at P ≤.05.
All regressions are adjusted for clustering by the family practice from which participants were recruited.

Ethical Approval

The Northern X Regional Ethics Committee approved this study (Reference NTX/06/09/108).

Results

The sample consisted of 934 participants from 9 practices, of whom 19% were at low CVD risk (<10% 5-year CVD risk), 35% were at moderate risk (10%-14% 5-year CVD risk), and the remaining 46% were at high or very high risk (15% 5-year CVD risk or higher).
Data were collected face to face from 689 participants and by telephone (95), mail (98), or mixed methods (52).
Most patients (61.8%) preferred a doctor to give an opinion than to explain using either numbers or pictures, and more than one-half (55.2%) preferred pictures to numbers.
There was no significant difference between men and women, or between ethnic groups, for those who preferred pictures to numbers.
There was no significant difference in preference for odds being presented between those who bet on horses and those who did not.
Logistic regression suggests that pictures are preferred over numbers, independently, by those with less schooling (OR=1.2; CI, 1.1-1.3) and by those who were less numerate (OR=1.1; CI, 1.01-1.2).
Short-term CVD risk explained only 7.4% of the variance of perceived likelihood of having a heart attack.
Perceived likelihood explained only 6.3% of variance in concern.
Concern explained only 1.4% of variance in keenness to take medication.
Keenness to take medication was not associated with ethnicity, age, sex, numeracy level, social deprivation score, concern about having a heart attack, preference for numbers or pictures, explanation or opinion, or first ranking of absolute risk reduction, natural frequencies, odds, or number needed to treat.
Keenness to take medication was positively associated with older age, higher CVD risk, perceived likelihood of having a heart attack, and having had only primary school education.
Perceived likelihood of having a heart attack was positively associated with increasing CVD risk, concern about having a heart attack, being Māori, and it was negatively associated with being more numerate and more educated.
Relative risk was ranked first by more numerate people (OR=1.2; 95% CI, 1.0-1.4), those who were more concerned about a heart attack (OR=1.1; 95% CI, 1.01-1.2), and less by Pacific Islander (OR=0.4) and Asian (OR=0.4) participants (ethnicity overall, 95% CI, 0.7-0.8).
No significant relationships were found for age, sex, education, social deprivation, keenness to take medication, perceived likelihood to have a heart attack, calculated cardiovascular risk, preference for pictures or numbers, positive or negative framing, or preference for explanation or opinion from the doctor.
This regression explained only 3% of the variance in the data.
Those who ranked absolute risk first were more likely to be Asian; those favoring natural frequencies were more likely to have lower literacy, follow horse racing, prefer pictures to numbers, and be Pacific Islander or Asian; and those favoring odds or number needed to treat were likely to follow horse racing and less likely to be concerned about a heart attack. This regression explained only 4.8% of variance in the data.

Discussion

Summary of Main Findings: More than 60% of participants preferred a doctor to give them an opinion on medication rather than explain the risks; slightly more than one-half preferred a pictorial presentation to numbers; and of the numerical presentations, nearly two-thirds preferred relative risk to other ways of presenting the same data. They did not distinguish between the mode of explanation that would encourage them to take medication and the mode they found most helpful to make a decision.
Statistically significant associations were found between various preferences, attitudes, and patient descriptors, but these associations explained only a small portion of the variance in the data, and the patterns were not sufficiently distinctive to be useful to clinicians in deciding how to communicate with an individual patient.
Strengths and Limitations of This Study: Strengths of this study include having consecutive patients; a wide range of age, ethnicity, and risk; and tailoring the questionnaires to the patients’ 5-year CVD risk.
The sample had more men than might be expected from a routine family practice clinic, which is attributed to the planned cardiovascular screening in several clinics, where men were invited as a priority and at a younger age because of their increased cardiovascular risk compared with women.
The options were always presented in the same order in the questionnaire: relative risk, absolute risk, number needed to treat, odds, and natural frequencies. There may have been some selection bias resulting from the order sequence, although the results indicate that this would only have been a minor effect. Nevertheless, to prevent such a possible bias, subsequent studies should present each option in random order.

Comparison With Existing Literature

In a previous study of preferred risk communication modes, among patients with preexisting heart disease, most would be encouraged to take medication regardless of mode of risk communication, although they preferred graphic representation and relative risk to other forms of communication.
The current study extends this work to patients across a much wider range of real cardiovascular risk, with a similar finding of overwhelming preference for relative risk.
Hux et al also found that patients are more likely to take preventative medication when benefits were expressed in terms of relative risk (“34% reduction in heart attacks”) than in absolute risk difference (“1.4% fewer people have heart attacks”) or number needed to treat (“treat 71 persons for 5 years to prevent 1 heart attack”).
A study that compared the likelihood of patients taking a hypothetical drug to prevent heart attacks expressed as number needed to treat (treat 13 people for 5 years to prevent 1 heart attack) with the therapy expressed in terms of postponing the heart attack (all patients who take the drug will live about 2 months longer), found number needed to treat was the most encouraging format. In this case, however, patients were comparing the possibility of not having a heart attack with a short prolongation of life; hence, it does not seem surprising that under these circumstances they would prefer the number needed to treat option.
A further study documented findings from focus groups of patients who were given their short-term CVD risk score to assess whether it assists in decisions to initiate various CVD reducing strategies. In discussion participants focused more on the relative or absolute risk reduction than on their level of CVD risk.
That the ethnic and socioeconomic status explained relatively little variance in the sample suggests that our results may be generalizable to other populations.

Implications for Future Research and Clinical Practice

Irrespective of education, numeracy score, socioeconomic status, or actual CVD risk, patients showed strong preference for relative risk as a means of encouraging them to take preventive medication. Reducing absolute risk from 5% to 3%, however, affords much less benefit than from 30% to 20% (the same relative risk reduction). Patients’ decisions to participate in a screening program can be influenced by the way information is presented, and discussing benefits only in terms of relative risk may overly influence their decision making.
We should not assume that patient choice necessarily indicates truly informed decision making, nor is it clear how to formally measure when a decision is ‘right’ or fully informed.
Because we cannot predict which mode of communication is preferred by individual patients, clinicians need to routinely use several modes and formats to communicate risk. In principle, clinicians should flexibly matching information to the needs of individuals.
Patients, however, still may have difficulty understanding descriptions of treatment benefit regardless of presentation, or simply prefer clinical opinion.
Widespread poor numeracy requires transparent risk communication such as absolute instead of relative risks and natural frequencies rather than conditional probabilities. Otherwise, our numbers and our words have the potential to manipulate patients.